MeSH tree: C12.950.419.192
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options ...
May 8, 2026
0
35
A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells—specifically B cells—that are linked to faster disease progression. The findings ...
Apr 29, 2026
0
4
Nonperfusion area detected by swept-source optical coherence tomography angiography (OCTA) may predict diabetic nephropathy (DN) severity, according to a study published in the July issue of the American Journal of Ophthalmology.
Apr 28, 2026
0
5
Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney disease following bariatric surgery in adolescents with type 2 diabetes and obesity, mechanisms that may serve as potential ...
Mar 23, 2026
0
3
Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells—also known as "zombie cells"—in diabetic kidney disease. In eBioMedicine, ...
Mar 5, 2026
0
11
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable information that significantly ...
Dec 22, 2025
0
15
Researchers from National Taiwan University Hospital and collaborating institutions have demonstrated that finerenone, a new-generation nonsteroidal mineralocorticoid receptor antagonist (MRA), significantly reduces the risk ...
Nov 26, 2025
0
26
A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a University of Bristol ...
Oct 14, 2025
0
26
A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to a study ...
Oct 1, 2025
0
21
A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney disease, diabetic retinopathy, and diabetic neuropathy. The study maps shared DNA signals, tests causal ...
Sep 30, 2025
0
16
